Sino Biological’s XpressMax cell-free kit accelerates AI-driven antibody screening by enabling rapid protein synthesis, high-throughput assays and tighter experimental loops.
How Sino Biological’s XpressMax Kit Speeds AI-Powered Antibody Discovery Read More »
Tolemy Bio raised €1.4M led by Norrsken Evolve to launch Orbit, an AI-native platform that turns lab experiments into reusable intelligence for mid-sized biopharma.
Tolemy Bio Raises €1.4M to Build Orbit, an AI Control Panel for Cell Biology Read More »
Authoritative overview of how AI is transforming biotechnology: drug discovery, precision diagnostics, bioprocess optimization, clinical trials and market outlook.
AI in Biotechnology: From Drug Discovery to Biomanufacturing Read More »
The Health + AI Insiders Tech Show, hosted by Insiders Intelligence Group, took place yesterday 29 April 2026
at Big Penny Social, London.
That’s a Wrap: The UK’s First Health + AI Tech Show Read More »
Discover how MOLEA uses AI to design K9 LNPs for selective mRNA delivery to chondrocytes, cutting liver uptake 13.5-fold and protecting cartilage via Mmp13 editing.
AI-Powered Precision: MOLEA Designs mRNA LNPs That Target Cartilage in Osteoarthritis Read More »
How AI is reshaping biotech: protein folding, drug discovery, personalized medicine, and next steps for validation, data standards, and regulation.
The AI Revolution in Biotechnology: From Protein Folding to Faster Drug Discovery Read More »
How AI accelerates biotech commercialization: practical strategies for R&D, clinical validation, and market entry in China and the silver economy with ethical data partnerships.
AI’s Strategic Role in Unlocking Biotech Commercialization Read More »
AI has set the stage for biotech and longevity. Learn how AI accelerates drug discovery, market size estimates, economic benefits and investor risks.
Beyond AI: Why Biotechnology and Longevity Are the Next Big Investment Wave Read More »
Scala Biodesign raised $16M to scale its AI platform for protein engineering. Learn how its technology could shorten drug development timelines and aid partners like Boehringer Ingelheim.
Scala Biodesign Raises $16M Series A to Speed AI-Driven Protein Design Read More »
How Generate Biomedicines uses generative AI to design protein therapeutics and advance candidates like GB-0895, GB-4362 and GB-5267 into the clinic.
Generate Biomedicines: Leveraging AI to Revolutionize Protein Drug Discovery Read More »
